-
REAL-WORLD BURDEN OF CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY IN ITALY: EPIDEMIOLOGY, TREATMENT PATTERNS, AND HEALTHCARE COSTS
Aug 11, 2026, 17:16 PM -
A REVIEW OF THE USE OF CORE OUTCOME SETS (COS) TO INFORM HEALTH TECHNOLOGY ASSESSMENTS
Aug 11, 2026, 17:16 PM -
MAPPING THE EDMONTON SYMPTOM ASSESSMENT SYSTEM-REVISED (ESAS-R) TO THE EQ-5D-5L IN PATIENTS WITH CANCER
Aug 11, 2026, 17:16 PM -
GENERIC INITIATION OR SUBSTITUTION VERSUS BRAND-NAME MEDICATIONS : A SYSTEMATIC REVIEW
Aug 11, 2026, 17:16 PM -
END-OF-LIFE CARE AGGRESSIVENESS IN PANCREATIC ADENOCARCINOMA: A RETROSPECTIVE OBSERVATIONAL STUDY
Aug 11, 2026, 17:16 PM -
THE IMPACT OF WORK LIFE BALANCE ON HEALTH OUTCOMES AND PRODUCTIVITY IN LOW- AND MIDDLE-INCOME COUNTRIES: A SYSTEMATIC REVIEW
Aug 11, 2026, 17:16 PM -
SUPPORTING EVIDENCE GENERATION THROUGH LIFE-CYCLE SCIENTIFIC ADVICE: FIVE-YEAR EXPERIENCE OF KOREA'S HTA GUIDE PROGRAM
Aug 11, 2026, 17:16 PM -
THE MISSING LINK: INTEGRATING EQ-5D FOR VALUE-BASED REIMBURSEMENT IN CEE VS. WESTERN EUROPE
Aug 11, 2026, 17:16 PM -
HEALTHCARE RESOURCE UTILIZATION (HCRU) AND ASSOCIATED COSTS IN PATIENTS WITH STAGE III MERKEL CELL CARCINOMA (MCC) TREATED WITH FIRST-LINE (1L) AVELUMAB IN A REAL-WORLD SETTING: RESULTS FROM THE MCC-TRIM REGISTRY
Aug 11, 2026, 17:16 PM -
THE IMPACT OF GERMANY'S 2008 NATIONWIDE SKIN CANCER SCREENING PROGRAM ON AGE-STANDARDIZED MELANOMA MORTALITY: AN UPDATE USING SYNTHETIC CONTROL METHODS
Aug 11, 2026, 17:16 PM -
WE-ACCESS-CLL SURVEY - REIMBURSEMENT AND ACCESS TO NOVEL FIRST-LINE TREATMENTS FOR CHRONIC LYMPHOCYTIC LEUKEMIA IN POLAND AND WESTERN EUROPE
Aug 11, 2026, 17:16 PM -
ESTIMATING THE RETURN ON PATIENT ENGAGEMENT IN CLINICAL TRIALS: EVIDENCE FROM A RISK-ADJUSTED NET PRESENT VALUE MODEL FOR A SOLID TUMOR ONCOLOGY PRODUCT
Aug 11, 2026, 17:16 PM -
COST-EFFECTIVENESS OF FIRST-LINE NIVOLUMAB-BASED THERAPY FOR HER2-NEGATIVE ADVANCED GASTRIC CANCER, GASTROESOPHAGEAL JUNCTION CANCER, AND ESOPHAGEAL ADENOCARCINOMA IN JAPAN
Aug 11, 2026, 17:16 PM -
EFFICACY AND SAFETY OF PALOPEGTERIPARATIDE IN CHRONIC HYPOPARATHYROIDISM - A SYSTEMATIC LITERATURE REVIEW
Aug 11, 2026, 17:16 PM -
FACTUAL OR EVALUATIVE? HOW THE LANGUAGE OF JOINT CLINICAL ASSESSMENT REPORTS SHAPES NATIONAL APPRAISAL
Aug 11, 2026, 17:16 PM -
REIMBURSEMENT AND CAPACITY IMPLICATIONS OF TRANSITIONING PATIENTS TO HOME-BASED SCIG IN SID AND CIDP: A PRACTICE-LEVEL ECONOMIC MODEL IN GERMANY
Aug 11, 2026, 17:16 PM -
ECONOMIC AND ORGANIZATIONAL ANALYSIS OF ES-SCLC IMMUNOTHERAPIES: A FRAMEWORK FOR APPROPRIATE SUSTAINABILITY IN THE ITALIAN NHS
Aug 11, 2026, 17:16 PM -
ESTIMATING THE HEALTH IMPACT OF INTENSIFYING LIPID-LOWERING THERAPY IN PATIENTS AT RISK FOR OR DIAGNOSED WITH ATHEROSCLEROTIC CARDIOVASCULAR DISEASE IN DENMARK
Aug 11, 2026, 17:16 PM -
EPIDEMIOLOGY, DISEASE MANAGEMENT, QUALITY OF LIFE, AND ECONOMIC BURDEN OF NON-SEGMENTAL VITILIGO IN FRANCE: A SYSTEMATIC LITERATURE REVIEW
Aug 11, 2026, 17:16 PM -
IMPACT ON HEALTHCARE RESOURCE UTILIZATION, COSTS, AND GREENHOUSE GAS EMISSIONS FOLLOWING SODIUM ZIRCONIUM CYCLOSILICATE INITIATION IN PATIENTS WITH HYPERKALAEMIA IN SPAIN: THE VITALIZE STUDY
Aug 11, 2026, 17:16 PM
